AIM ImmunoTech Files 8-K on Shareholder Vote Matters
Ticker: AIM · Form: 8-K · Filed: Dec 17, 2025 · CIK: 946644
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
AIM ImmunoTech filed an 8-K for a shareholder vote on Dec 16th. Details TBD.
AI Summary
AIM ImmunoTech Inc. filed an 8-K on December 17, 2025, reporting on matters submitted to a vote of security holders as of December 16, 2025. The filing does not contain specific details about the vote or the matters discussed.
Why It Matters
This filing indicates that AIM ImmunoTech Inc. held a vote of its security holders, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote without immediate financial or operational impact detailed within the provided text.
Key Players & Entities
- AIM ImmunoTech Inc. (company) — Registrant
- December 16, 2025 (date) — Date of earliest event reported
- December 17, 2025 (date) — Date of report
- 001-27072 (other) — SEC File Number
- 52-0845822 (other) — I.R.S. Employer Identification No.
FAQ
What specific matters were submitted to a vote of AIM ImmunoTech Inc. security holders?
The provided text of the 8-K filing does not specify the exact matters that were submitted to a vote of security holders.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 16, 2025.
What is the SEC File Number for AIM ImmunoTech Inc.?
The SEC File Number for AIM ImmunoTech Inc. is 001-27072.
What is the principal executive office address for AIM ImmunoTech Inc.?
The principal executive office address for AIM ImmunoTech Inc. is 2117 SW Highway 484, Ocala, FL 34473.
What is the I.R.S. Employer Identification Number for AIM ImmunoTech Inc.?
The I.R.S. Employer Identification Number for AIM ImmunoTech Inc. is 52-0845822.
Filing Stats: 881 words · 4 min read · ~3 pages · Grade level 11.8 · Accepted 2025-12-17 16:30:51
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share AIM NYSE American Indic
Filing Documents
- form8-k.htm (8-K) — 45KB
- 0001493152-25-028156.txt ( ) — 206KB
- aim-20251216.xsd (EX-101.SCH) — 3KB
- aim-20251216_lab.xml (EX-101.LAB) — 33KB
- aim-20251216_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AIM ImmunoTech Inc. Date: December 17, 2025 By: /s/ Thomas K. Equels Thomas K. Equels, CEO